Patritumab

MedChem Express

Patritumab

10

Research Use Only

Monoclonal

98.95

Patritumab (Human Anti-ERBB3 Recombinant Antibody) is a neutralizing monoclonal antibody to ERBB3 . Patritumab shows a synergy with Cetuximab (HY-P9905), potently inhibits the phosphorylation of EGFR , HER2 , HER3 , ERK , and AKT . Patritumab also induces cell apoptosis and suppresses the growth of pancreatic, non-small cell lung cancer, and colorectal cancer xenograft tumors [1] .

-80°C

12352203